Limbocker, Ryan
Chia, Sean
Ruggeri, Francesco S.
Perni, Michele http://orcid.org/0000-0001-7593-8376
Cascella, Roberta
Heller, Gabriella T.
Meisl, Georg http://orcid.org/0000-0002-6562-7715
Mannini, Benedetta http://orcid.org/0000-0001-6812-7348
Habchi, Johnny
Michaels, Thomas C. T.
Challa, Pavan K.
Ahn, Minkoo http://orcid.org/0000-0001-9131-7334
Casford, Samuel T.
Fernando, Nilumi
Xu, Catherine K.
Kloss, Nina D.
Cohen, Samuel I. A.
Kumita, Janet R. http://orcid.org/0000-0002-3887-4964
Cecchi, Cristina
Zasloff, Michael
Linse, Sara http://orcid.org/0000-0001-9629-7109
Knowles, Tuomas P. J.
Chiti, Fabrizio http://orcid.org/0000-0002-1330-1289
Vendruscolo, Michele
Dobson, Christopher M. http://orcid.org/0000-0002-3616-1610
Article History
Received: 31 May 2018
Accepted: 5 November 2018
First Online: 15 January 2019
Competing interests
: The authors declare the following competing interests: M.Z. is one of the inventors in a patent for the use of trodusquemine in the treatment of Parkinson’s disease. C.M.D., M.V., S.I.A.C., T.P.J.K., J.H. and S.L. are co-founders of Wren Therapeutics Limited, which is independently pursuing inhibitors of protein misfolding and aggregation. The remaining authors declare no competing interests.